Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference

Vanda Pharmaceuticals (Nasdaq: VNDA) will participate in the J.P.

Rhea-AI Summary

Vanda Pharmaceuticals (Nasdaq: VNDA) will participate in the J.P. Morgan Healthcare Conference in San Francisco on January 15, 2026. A corporate presentation is scheduled for 9:00 a.m. PT / 12:00 p.m. ET. The presentation will be accessible live via Vanda's website under the Investors > Recent Events section.

Investors are advised to visit the conference website at least 15 minutes early to register and install any required software. A link to the archived presentation will be available on Vanda's website for approximately 30 days after the event.

Argus Dec 12 session

-5.61% close to close Open Argus

Details

News Market Reaction – VNDA

On Dec 12, the first trading day after this news, VNDA closed 5.61% below the previous close.

Data tracked by StockTitan Argus for the Dec 12 session.

Market Context

On Dec 12, the first trading day after this news, the stock closed 5.6% below the previous close. A ...

Analysis

On Dec 12, the first trading day after this news, the stock closed 5.6% below the previous close. A negative reaction despite a routine conference update would fit a pattern where not all news items have been rewarded, even amid important clinical and regulatory milestones. With shares previously near the 52-week high, some moves have followed earnings or guidance shifts. In assessing a decline around this type of neutral event, historical behavior around non-data announcements and broader sentiment toward the pipeline could be important contextual factors.

Key Figures

Conference date: January 15, 2026 Presentation time (PT): 9:00 a.m. Presentation time (ET): 12:00 p.m. +2 more

Conference date

January 15, 2026

Scheduled J.P. Morgan Healthcare Conference presentation date

Presentation time (PT)

9:00 a.m.

Scheduled corporate presentation Pacific Time

Presentation time (ET)

12:00 p.m.

Scheduled corporate presentation Eastern Time

Early login window

15 minutes

Suggested early login to register and install software

Archive duration

30 days

Archived conference link availability on Vanda’s website

Historical Context

5 past events · Latest: Dec 04

5 events

1. Dec 04

   Regulatory update

   24h Move

   -0.8%

   FDA lifted partial clinical hold on tradipitant protocol VP-VLY-686-3403.

2. Nov 28

   Regulatory update

   24h Move

   +1.1%

   FDA expedited re-review and confirmed tradipitant PDUFA 12/30/2025.

3. Nov 17

   Clinical data

   24h Move

   +1.1%

   Tradipitant reduced GLP-1–induced vomiting with significant p-values and good safety.

4. Nov 05

   Conference participation

   24h Move

   -0.7%

   Announcement of corporate presentation at Stifel 2025 Healthcare Conference.

5. Oct 29

   Earnings and pipeline

   24h Move

   -3.0%

   Q3 loss, lowered 2025 guidance, and multiple upcoming PDUFA and BLA milestones.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WASHINGTON, Dec. 11, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the J.P. Morgan Healthcare Conference in San Francisco, California on Thursday, January 15, 2026.  A corporate presentation is scheduled for 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time).

The corporate presentation given at the J.P. Morgan Healthcare Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-jp-morgan-healthcare-conference-302639678.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Vanda Pharmaceuticals (VNDA) present at the J.P. Morgan Healthcare Conference?

Vanda will present on January 15, 2026 at 9:00 a.m. PT / 12:00 p.m. ET.

How can investors watch the VNDA presentation live on January 15, 2026?

Watch live via Vanda's website under Investors > Recent Events using the provided webcast link.

Will the VNDA presentation at J.P. Morgan be available after the event?

Yes. An archived link will remain on Vanda's website for approximately 30 days after the presentation.

What time should I join the J.P. Morgan event page for the VNDA presentation?

Investors are advised to arrive at the conference website at least 15 minutes early to register and install any required software.

Where on Vanda's site is the J.P. Morgan presentation located for VNDA investors?

Go to Vanda's corporate website, click the Investors tab, and select the link under Recent Events.

Is prior registration required to view Vanda's VNDA presentation at the conference?

Yes. Attendees should register on the conference website and complete any software downloads before the start time.